Drawing for Serial No. 79061728

USPTO serial 79061728

Serial No. 79061728

Reviewed by CopyMark Law Group

Reg. 3734388Status 404
Filing date
Status date
Registration date
Jan 5, 2010
Examiner
BIBB, SCOTT
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79061728?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for diagnosis and treatment of human diseases and disorders, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, cell-proliferate, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious, metabolic or central nervous system diseases or disorders; the above-mentioned preparations also as pharmaceutical preparations for medical diagnostic purposes or therapeutic purposes; veterinary preparations for livestock, cats, dogs and rodents, namely, for the treatment and prevention of circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, cell-proliferate, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious, metabolic or central nervous system diseases or disordersSECTION 71 - CANCELLED—
016Printed matter, namely, books and magazines in the field of medicine, veterinary medicine and biotechnology; office supplies except furniture, namely, pencils, staplers, adhesive tapes, hole punchers, erasers, rulers; transfers; stickers; banknote clips; letter paper; brochures in the field of medicine; paper labels; stationery; fountain pens and other writing utensils, namely, artists' brushes, ballpens, felt pens, highlighters, permanent markers; calendars; greeting cards; catalogues in the field of medical, veterinary, and biotechnology products; bookmarks; note books and note pads; picture postcards, coasters of paper and boxes of cardboard or paper; instructional and teaching materials, namely, worksheets in the field of biology, medicine and biotechnology; instructional and teaching materials, namely, printed workbooks, for seminars and workshops in the field of the treatment of cancer and cancer research, of healthcare, of medical science and of pharmaceutical research and of the use of pharmaceuticals; packaging material made out of plastic, namely, plastic bags for packing, plastic bubble packs for wrapping or packagingSECTION 71 - CANCELLED—
041Education services, namely, providing seminars in the field of medicine and oncology; providing of training in the field of medicine; organization and realization of educational workshops and seminars all in the field of the treatment of cancer, cancer research, healthcare, of medical science as well as of pharmaceutical research and of the use of pharmaceuticals; organization and realization of conferences and congresses in the field of medical science, of healthcare, of pharmaceutical research and of the use of pharmaceuticals, in particular in the field of the treatment of cancer and cancer researchSECTION 71 - CANCELLED—
042Research and development in the field of pharmaceutics and medical science, in particular for the treatment of cancer and cancer research; scientific and medical research and development in the field of biotechnology with regard to human beings and animals, including mission-oriented research; designing and developing computer programs in the field of biotechnology and medical science, in particular of genomics, proteomics, pharmaceutical preparations, medical therapeutics and medical diagnostics; conducting scientific analyses in the field of biotechnology as well as of medical science and the treatment of cancer and cancer researchSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 18, 2018DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
May 18, 2018DETHDEATH OF INTERNATIONAL REGISTRATION—
May 26, 2017INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Apr 14, 2017INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Apr 14, 2017INPCINVALIDATION PROCESSED—
Apr 12, 2017INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 12, 2016C71TCANCELLED SECTION 71—
Feb 5, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 20, 2010CHLDCHANGE OF OWNER RECEIVED FROM IB—
May 3, 2010FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 3, 2010FIMPFINAL DISPOSITION PROCESSED—
Apr 5, 2010FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 5, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 20, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 30, 2009NPUBNOTICE OF PUBLICATION—
Sep 15, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 14, 2009CNEAEXAMINERS AMENDMENT MAILED—
Sep 11, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 11, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Sep 11, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 11, 2009ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Sep 10, 2009PBSRWITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST—
Sep 9, 2009CNEAEXAMINERS AMENDMENT MAILED—
Sep 8, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 8, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 8, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Sep 8, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 8, 2009ZZBXALLOWANCE WITHDRAWN-INADVERTENTLY ISSUED ACTION—
Aug 18, 2009PBSRWITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST—
Aug 3, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 3, 2009ALIEASSIGNED TO LIE—
Jul 24, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 17, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 17, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 17, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 5, 2009RFNTREFUSAL PROCESSED BY IB—
Dec 29, 2008RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 29, 2008RFRRREFUSAL PROCESSED BY MPU—
Dec 19, 2008MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 16, 2008RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 15, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 15, 2008DOCKASSIGNED TO EXAMINER—
Dec 15, 2008NWAPNEW APPLICATION ENTERED—
Dec 12, 2008REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance